Location History:
- Uppsala, SE (2001 - 2012)
- Molndal, SE (2006 - 2014)
Company Filing History:
Years Active: 2001-2014
Title: The Innovative Contributions of Sverker Ljunghall
Introduction
Sverker Ljunghall is a notable inventor based in Molndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bone resorption diseases. With a total of six patents to his name, Ljunghall's work has the potential to impact many lives.
Latest Patents
Among his latest patents is a combined pharmaceutical preparation that includes parathyroid hormone and a bone resorption inhibitor. This innovative preparation is designed for the administration of parathyroid hormone over a period of approximately 6 to 24 months. Following the termination of parathyroid hormone administration, the preparation allows for the administration of a bone resorption inhibitor for an additional period of approximately 12 to 36 months. This dual approach aims to enhance treatment efficacy for patients suffering from bone resorption diseases.
Career Highlights
Sverker Ljunghall has worked with several prominent companies in the pharmaceutical industry, including NPS Allelix Corporation and NPS Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in developing effective treatments.
Collaborations
Throughout his career, Ljunghall has collaborated with notable colleagues such as John Dietrich and Sven Sjogren. These partnerships have likely fostered a creative environment that encourages the development of groundbreaking solutions in the pharmaceutical field.
Conclusion
Sverker Ljunghall's contributions to the treatment of bone resorption diseases through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.